MedTrace Logo

A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

NCT03532126 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2024-12-10

No results posted yet for this study

Summary

This investigation aims to confirm the safety and effectiveness of Princess VOLUME PLUS Lidocaine in midface volume deficit augmentation and includes a long term safety followup.

Conditions

  • Midface Volume Deficit

Interventions

DEVICE

Dermal filler for midface deficit

During this procedure the device (a dermal filler) will be deep intradermal, subcutaneous or supraperiosteal injected according to its CE mark.

Sponsors & Collaborators

  • FGK Clinical Research GmbH

    collaborator INDUSTRY

  • Croma-Pharma GmbH

    lead INDUSTRY

Principal Investigators

  • Martin Prinz, Mag. · Sponsor GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-28
Primary Completion
2019-07-24
Completion
2020-06-30

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532126 on ClinicalTrials.gov